Inverse association of eosinophil count with colorectal cancer incidence: Atherosclerosis Risk in Communities study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 9, 2011, Pages 1861-1864

  Prizment, Anna E ^a   Anderson, Kristin E ^a,b   Visvanathan, Kala ^c   Folsom, Aaron R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; CANCER INCIDENCE; COLON CANCER; COLORECTAL CANCER; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECTUM CANCER; RISK;

AGED; ATHEROSCLEROSIS; COLORECTAL NEOPLASMS; EOSINOPHILS; FEMALE; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 80052520507     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0360     Document Type: Article

References (27)

1. Turner A.R. Epidemiological evidence: IgE, atopy, and solid tumors. In: Penichet ML, Jensen-Jarolim E, editors. Cancer and IgE. London: Spinger Science; 2010. p. 47-77.
2. Wang H., Diepgen T.L. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005;60:1098-1111 (Pubitemid 41153134)
3. Martínez-Maza O., Moreno A.D., Cozen W. Epidemiological evidence: IgE, allergies, and hematopoietic malignancies. In:Penichet ML, Jensen-Jarolim E, editors. Cancer and IgE. London: Springer Science; 2010. p.79-136.
4. Merrill R.M., Isakson R.T., Beck R.E. The association between allergies and cancer: What is currently known? Ann Allergy Asthma Immunol 2007;99:117-119
5. Sherman P.W., Holland E., Sherman J.S. Allergies: Their role in cancer prevention. Q Rev Biol 2008;83:339-362
6. Vojtechova P., Martin R.M. The association of atopic diseases with breast, prostate, and colorectal cancers: A meta-analysis. Cancer Causes Control 2009;20:1091-1105
7. Prizment A.E., Folsom A.R., Cerhan J.R., Flood A., Ross J.A., Anderson K.E. History of allergy and reduced incidence of colorectal cancer, Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2007;16:2357-2362 (Pubitemid 351196368)
8. Pages F., Galon J., Fridman W.H. The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol 2008;84:981-987
9. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-3109
10. Fernndez-Aceero M.J., Galindo-Gallego M., Sanz J., Aljama A. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 2000;88:1544-1548 (Pubitemid 30183138)
11. Legrand F., Driss V., Delbeke M., Loiseau S., Hermann E., Dombrowicz D., et al. Human eosinophils exert TNF-a and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol 2010;185:7443-7451
12. Nielsen H.J., Hansen U., Christensen I.J., Reimert C.M., Brunner N., Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999;189:487-495
13. American Cancer Society, Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010.
14. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
15. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997;96:1102-1108 (Pubitemid 27344210)
16. Prizment A.E., Anderson K.E., Visvanathan K., Folsom A.R. Association of inflammatory markers with colorectal cancer incidence in the Atherosclerosis Risk in Communities (ARIC) study. Cancer Epidemiol Biomarkers Prev 2011;20:297.
17. Duncan B.B., Schmidt M.I., Offenbacher S., Wu K.K., Savage P.J., Heiss G. Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 1999;22:767-772 (Pubitemid 29220777)
18. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36. (Pubitemid 43941640)
19. Singer J.D., Willett J.B. Applied longitudinal data analysis. New York: Oxford University Press; 2003. p. 586-596
20. Fauci A.S., Braunwald E., Kasper D.L., et al. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Professional; 2009.
21. Rothenberg M.E. Eosinophilia. N Engl J Med 1998;338:1592-1600
22. Dhar S., Malakar R., Chattopadhyay S., Dhar S., Banerjee R., Ghosh A. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels. Indian J Dermatol Venereol Leprol 2005;71:246-249 (Pubitemid 41191360)
23. Spencer L.A., Szela C.T., Perez S.A., Kirchhoffer C.L., Neves J.S., Radke A.L., et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 2009;85:117-123
24. Cormier S., Taranova A., Bedient C., Nguyen T., Protheroe C., Pero R., et al. Pivotal advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006;79:1131-1139 (Pubitemid 44835546)
25. Simson L., Ellyard J.I., Dent L.A., Matthaei K.I., Rothenberg M.E., Foster P.S., et al. Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance. J Immunol 2007;178:4222-4229 (Pubitemid 46492372)
26. Munitz A., Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004;59:268-275 (Pubitemid 38339842)
27. Jensen-Jarolim E., Achatz G., Turner M.C., Karagiannis S., Legrand F., Capron M., et al. AllergoOncology: The role of IgE-mediated allergy in cancer. Allergy 2008;63:1255-1266